Department of Medicine, University of Udine, 33100 Udine, Italy.
Institute of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Cells. 2020 Dec 30;10(1):44. doi: 10.3390/cells10010044.
Madelung Disease (MD) is a syndrome characterized by the accumulation of aberrant symmetric adipose tissue deposits. The etiology of this disease is yet to be elucidated, even though the presence of comorbidities, either genetic or environmental, has been reported. For this reason, establishing an in vitro model for MD is considered crucial to get insights into its physiopathology. We previously established a protocol for isolation and culture of stem cells from diseased tissues. Therefore, we isolated human adipose-derived stem cells (ASC) from MD patients and compared these cells with those isolated from healthy subjects in terms of surface phenotype, growth kinetic, adipogenic differentiation potential, and molecular alterations. Moreover, we evaluated the ability of the MD-ASC secretome to affect healthy ASC. The results reported a difference in the growth kinetic and surface markers of MD-ASC compared to healthy ASC but not in adipogenic differentiation. The most commonly described mitochondrial mutations were not observed. Still, MD-ASC secretome was able to shift the healthy ASC phenotype to an MD phenotype. This work provides evidence of the possibility of exploiting a patient-based in vitro model for better understanding MD pathophysiology, possibly favoring the development of novel target therapies.
Madelung 病(MD)是一种以异常对称脂肪组织沉积为特征的综合征。尽管已经报道了遗传或环境共存的合并症,但这种疾病的病因仍未阐明。因此,建立 MD 的体外模型被认为对于深入了解其病理生理学至关重要。我们之前已经建立了从患病组织中分离和培养干细胞的方案。因此,我们从 MD 患者中分离出人类脂肪来源干细胞(ASC),并在表面表型、生长动力学、成脂分化潜能和分子改变等方面将这些细胞与从健康受试者中分离出的细胞进行比较。此外,我们评估了 MD-ASC 分泌组对健康 ASC 的影响能力。结果报告称,与健康 ASC 相比,MD-ASC 的生长动力学和表面标志物存在差异,但成脂分化没有差异。最常描述的线粒体突变并未观察到。尽管如此,MD-ASC 分泌组能够将健康 ASC 的表型转变为 MD 表型。这项工作为利用基于患者的体外模型来更好地理解 MD 病理生理学提供了证据,可能有利于新的靶向治疗药物的开发。